Stockreport

4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geographic Atrophy [Yahoo! Finance]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF Complement factor H (CFH) variants with reduced function are a well-validated genetic risk factor for geographic atrophy (GA), with approximately 75% of age-related mac [Read more]